Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Low vitamin D levels are linked to increased risk of male pattern baldness.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Finasteride improves hair growth in men with androgenetic alopecia.

Men who think they are losing hair feel worse about themselves, especially if they are younger.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Elderly abuse is often by family members, and doctors, especially dermatologists, can spot it by looking for unusual injuries and malnutrition.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Combined microneedling and minoxidil improves hair growth more than minoxidil alone.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Acyclovir cream may slow down hair growth, suggesting it could be a new treatment for excessive hairiness.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.